Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Pain 1Liver Neoplasms 1Inflammation 1Endobronchial Metastases 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

palbociclib 2montelukast 1ginger extract 1Weights and Measures 1Vitamin D 1Tablets 1Sufentanil 1Rivaroxaban 1Oxycodone 1Omeprazole 1Morphine 1Lidocaine 1Ibuprofen 1Hyperspectral Imaging 1Fish Oils 1Eating 1Diet Records 1Dexmedetomidine 1Dexlansoprazole 1Calcium 1CHR 2845 1Body Height 1Blood Specimen Collection 1Bevacizumab 1Basal Metabolism 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammation × Oxycodone × Gastrointestinal × Clear all
NCT06041425 2024-02-28

The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

The First Affiliated Hospital with Nanjing Medical University

Phase 4 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Inflammation, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡